Home » Valor Medical and Execs Plead Guilty to Concealing Device Toxicity From FDA
Valor Medical and Execs Plead Guilty to Concealing Device Toxicity From FDA
California biotech Valor Medical, four executives and a consultant have admitted to the Department of Justice that they concealed information about their Neucrylate diagnostic assay, hiding toxicity reports that were required as the product was undergoing FDA premarket review.
MassDevice
MassDevice
Upcoming Events
-
14May
-
23May
-
30May
-
20Jun
-
21Oct